Search for Clinical Trial Results

Sponsored By

Dysferlinopathy - 4 Studies Found

Status Study
Recruiting Study Name: rAAVrh74.MHCK7.DYSF.DV for Treatment of Dysferlinopathies
Condition: Dysferlinopathy
Date: 2016-02-11
Interventions: Drug: rAAVrh74.MHCK7.DYSF.DV Biological/Vaccine: rAAVrh74.MHCK7.DYSF.DV Recombinant adeno-associated vir
Completed Study Name: Deflazacort in Dysferlinopathies
Condition:
  • LGMD2B
  • Miyoshi Myopathy
  • Dysferlinopa
    Date: 2007-09-06
    Interventions:
    • Drug: deflazacort In the first
Active, not recruiting Study Name: Clinical Outcome Study for Dysferlinopathy
Condition:
  • Dysferlinopathy
  • LGMD2B
  • Miyosh
    Date: 2012-08-28
Recruiting Study Name: Proteasomal Inhibition for Patients With Mis-sense Mutated Dysferlin
Condition: Dysferlinopathy
Date: 2013-04-29
Interventions: Drug: Bortezomib Other Name: Velcade®